Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.14% | 3.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.14% | 3.03% | |||
| Cost of Revenue | -2.50% | 4.05% | |||
| Gross Profit | -1.59% | 1.51% | |||
| SG&A Expenses | 5.50% | -1.64% | |||
| Depreciation & Amortization | -16.88% | 11.73% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.25% | 2.28% | |||
| Operating Income | -37.43% | 19.46% | |||
| Income Before Tax | -110.89% | 201.45% | |||
| Income Tax Expenses | -106.35% | 270.05% | |||
| Earnings from Continuing Operations | -112.60% | 188.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -112.60% | 188.06% | |||
| EBIT | -37.43% | 19.46% | |||
| EBITDA | -41.15% | 16.57% | |||
| EPS Basic | -112.24% | 189.09% | |||
| Normalized Basic EPS | -108.89% | 215.38% | |||
| EPS Diluted | -112.24% | 189.09% | |||
| Normalized Diluted EPS | -108.89% | 215.38% | |||
| Average Basic Shares Outstanding | 3.80% | 0.00% | |||
| Average Diluted Shares Outstanding | 3.04% | 0.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||